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Developmental stages of mammary glands influence their susceptibility to initiating events related to 
carcinogenesis. The “window of susceptibility” to mammary carcinogenesis is classically defined as the time in 
early puberty when the mammary gland morphology is most sensitive to initiation events. Administration of the 
polyaromatic hydrocarbon, 7,12-dimethylbenz(a)anthracene (DMBA), in a single oral dose yields maximal 
mammary tumor formation when administered in this “window”. We examined the DMBA treated mammary 
glands, precursor lesions, and morphology of the uninvolved mammary epithelium for the first 100 days of life 
for Charles River Sprague Dawley CDR IGS. Our goal was to determine the DMBA dose at which 50% of the rats 
(IC50) developed carcinoma in situ (CIS) within three months of dosing. Here we demonstrate, rather than the 
classical U-shaped dose curve in which there is maximum sensitivity for DMBA at 50 days, there is an increasing 
degree of sensitivity with age in the CDR IGS rat. Additionally, we report that vehicle-treated animals developed 
mammary CIS without any known initiator, and 100 day virgin animals demonstrated lactational changes, 
independent of DMBA exposure or dose. Lastly, we demonstrate this strain of virgin female rats has elevated 
pituitary prolactin immunoreactivity independent of the level of mammary differentiation. We conclude this 
strain of Charles River Sprague Dawley rats has prolactin-induced pituitary stimulation, and therefore, the 
window of susceptibility for mammary tumorigenesis is absent. 
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1.  Introduction 
Research on rodent mammary gland 
carcinogenesis and observational studies in human 
populations has focused on the premise that the breast 
has a unique age at which carcinogen exposure is 
maximally affective. This ‘window of susceptibility’ is 
thought to be a major predictor of cancer risk.  
Extensive comparisons have been made between 
rat and human mammary pathologies [1; 2]. The rat 
mammary chemical carcinogenesis model has been 
extremely well studied and is commonly used to ask 
questions about mechanisms of tumorigenesis 
throughout the lifespan of the animal. One of the major 
questions regarding mammary carcinogenesis is the 
mechanism by which mammary glands at different 
stages of development display a differential sensitivity 
to initiating events. Mammary gland development 
begins with a single lactiferous duct giving rise 
primitive ductules at birth [3]. The lobule begins as a 
terminal end bud (TEB), which differentiates into 
alveolar buds (AB). AB develop to become the terminal 
ductolobular unit (TDLU), containing the stem cells 
from which all TDLU cells are derived [4]. Detailed 
analysis of human tumors shows that the site of origin 
is the TDLU or the lobule [5]. The “window of 
susceptibility” to mammary carcinogenesis is 
classically defined as the time in early puberty in 
which there is maximum burst of TEB proliferation 
and development into AB [6; 7].  
Administration of the polyaromatic hydrocarbon, 
7,12-dimethylbenz(a)anthracene (DMBA), in a single 
oral dose yields maximal mammary tumor formation 
when administered in this “window” [8]. Among 
strains, the outbred Sprague Dawley (SD) rats are 
among the most sensitive to carcinogen-induced 
mammary cancers [4; 9]. The early work identifying 
the mammary window of susceptibility showed that 
the peri-pubescent period of about 45-50 days of age 
was consistently found to be the time of optimal 
sensitivity for initiation with the model polyaromatic 
hydrocarbon DMBA [6; 8]. This model is well-known 
for the production of tumors that are morphologically 
heterogeneous and hormone dependent.  
A number of studies have highlighted the fact 
that there is genetic strain divergence in rodent 
breeding colonies [10-13]. Therefore, we undertook the 
task of identifying the time span within the first 100 
days of life in which the Charles River Sprague 
Dawley CD
R IGS rat that is most susceptible to mammary Int. J. Biol. Sci. 2007, 3 
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carcinogenesis. The Charles River Sprague Dawley CD
R IGS 
is known to have come to Charles River in 1950 from 
Sprague Dawley Inc. In 1991, 8 colonies were selected to 
form the IGS Foundation Colony using the Charles River 
International Genetic Standard System. Our research goal 
was to calculate a dose of DMBA at each age in which 50% 
of the rats developed carcinoma in situ (CIS) within three 
months (IC50) in this strain of Sprague Dawley female 
rats. 
2.  Methods 
DMBA Treatment and Tissue Isolation: 
Virgin female Sprague Dawley CD (CDR IGS) rats 
were purchased at three different ages: weaning (21 
days), peri-pubertal (45 days), or mature (100 days) 
from Charles River Laboratories (all shipments were 
from either the Portage, MI or Raleigh, NC, breeding 
facilities). Upon arrival from Charles River the SD CD 
rats were placed on AIN-93G or AIN-93M defined diet 
(Bio-Serv, Inc.), absent phyoestrogens, and wood chip 
bedding. Animals were kept on a strict 12 hour light 
cycle to maintain circadian rhythm. For carcinogenesis 
studies, DMBA (Fisher Acros, Fisher Scientific) was 
dissolved in filter sterilized corn oil at (2-15mg/mL 
depending on BW dissolved at 95-96 C) cooled to room 
temp and administered with an enterral feeding tubing 
(Vygon, Inc.) under light isoflurane anesthesia. Based 
upon historical published studies [14-21] , we chose the 
following DMBA dosages as a single oral gavage for 
each age under examination: 21 days old: 20, 50, and 
100 mg/kg; 50 days old: 10, 30, and 60 mg/kg; and 100 
days old: 25, 50, and 80 mg/kg (n = 20 for each dose 
and each age). Corn oil was administered by gavage 
for the vehicle control group (n=5). Animals were 
palpated weekly for tumor formation. Three months 
post-DMBA exposure, all animals were sacrificed . At 
this time, all tumors and uninvolved mammary tissue 
were saved by formalin fixation for paraffin 
embedding and later histological characterization. 
Masses and precursor histology were identified as 
previously published by our laboratory [14; 22; 23] and 
according to the criteria of the Russos [24].  
By the Russo criteria, an intraductal proliferation 
initiated (IDPi) is the very earliest form of ductal 
hyperplasia in the DMBA model, whereas intraductal 
proliferation promoted (IDPp )  i s  a  f o r m  o f  d u c t a l  
hyperplasia with cellular atypia [4]. These proliferative 
lesions occur in clusters and patches within lobules, so 
each lobule containing one or more alveolus with IDPp 
i s  c o u n t e d  a s  o n e .  C I S  i s  t h e  n e x t  i n  s i t u  s t a g e  o f  
disease. CIS is often found within a benign adenoma or 
fibroadenoma, in which case the tumor is called CIS. 
Pure adenomas or fibroadenomas are counted as 
benign tumors. Once a malignant tumor has broken 
through the epithelial basement membrane and is 
invading adjacent stroma it is termed invasive (INV). 
INV is always derived from CIS, as previously noted 
[14]. Photomicrographs of each diagnostic category 
from our laboratory have been previously published 
[14]. Data from the current studies were compared to 
historical data from our laboratory in Sprague Dawley 
rats purchased from Taconic in which DMBA was 
administered at 50 days of age.   
Mammary Morphological Characterization 
In order to characterize the morphology of the 
mammary gland at the time of DMBA exposure, 
additional rats were acquired from Charles River 
(Portage, MI) at 21, 50, and 100 days of age, three per 
group. At sacrifice, mammary gland four was prepared for 
whole mount analysis. Abdominal-inguinal mammary tissue 
containing glands 4, 5, and 6 were excised in one piece and 
pinned to boards for fixation in 10% alcoholic formalin. 
After complete defatting with acetone, tissues were hydrated 
using a series of alcohols for 1 hour each and left in water 
overnight prior to staining for 2 hours with 0.025% toluidine 
blue. Once staining was complete, the whole mount 
preparations were destained using methanol and 70% 
ethanol and fixed briefly in ammonium molybdate and 
rehydrated. Finally xylene was used to clear the tissue 
preparations. Tissues were mounted on slides using 
permount for further examination and analysis.  
  All whole mount images were captured using a 
Q Color 5 digital camera (Olympus, Tokyo Japan) into 
digital images. Using the QCapture Pro software, 
measurements were made detailing the size and 
complexity of gland 4. Area, area of epithelium, 
distance from nipple to lymph node, distance from 
superior lymph node to branch border, and distance 
from nipple to first lateral branch were all measured. 
Individual structures in defined regions of the ductal 
extensions into the mammary fat pad of abdominal 
gland 4 commonly known as zone C were counted 
according to the criteria of Russo and Russo [8] at 50 
and 100 days. Structures from throughout the gland 
were counted at 21 days. Classic descriptive criteria [3] 
as well as the following measurement criteria were 
used for counting structures: TEB >85 microns and TD 
58-84 microns. Approximately one thousand structures 
per animal were counted at 108X (Olympus, Tokyo 
Japan). Of the remaining glands, half were formalin 
fixed for histology. Pituitaries were fixed in formalin 
and paraffin embedded for histological and 
immunohistochemcial analysis.   
Immunohistochemistry 
All immunohistochemistry was performed using 
Ventana XT automatic immunostaining system, , with 
the Ventana I view DAB detection kit as described 
previously [14]. Preimmune Rabbit IgG or 
isotype-specific mouse IgG was added in place of the 
primary antibody as negative controls. Histologic 
sections were stained by immunohistochemistry for 
prolactin (monoclonal antibody Immunotech, clone 
16422-12, 1:400 dilution with Ventana protease I 
digest) and PCNA (Vecter, clone pc10, 1:800 dilution 
with Ventana cell conditioner I mild). Rat adsorbed 
anti-mouse (Vector Laboratories, Burlingame, CA) was 
used as the secondary antibody at a 1:50 dilution. 
Statistical methods 
All statistical evaluations were performed using 
SigmaStat (SPSS, Chicago, Illinois). Group mean Int. J. Biol. Sci. 2007, 3 
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comparisons were by one-way ANOVA, two sided, 
using 95% confidence intervals. Two group 
comparisons were by Student’s t test.  
3.  Results  
Charles River Sprague Dawley Female Rats Lack 
the ‘Traditional’ Window of Susceptibility to 
DMBA-Induced Carcinogenesis 
The percentage of rats with CIS plus INV 
(tumors) for each DMBA dose at each age of exposure 
is shown in Figure 1. Benign tumors (adenoma and 
fibroadenomas) are excluded. Note that the DMBA 
dose is not directly comparable among cohorts by age. 
In the 21 and 50 day cohorts incidence shows a dose 
dependent response, reaching 100% incidence at the 
highest dose given. The 100 day cohort lacks a dose 
response curve and the maximum incidence reached 
was 80%. Of note, the control animals from the 100 day 
cohort had an incidence of CIS of 20%. At the time of 
sacrifice these rats were between six and six and a half 
months old; a young age for spontaneous mammary 
tumor formation.  
 
Figure 1. Percent of rats with CIS or INV when treated with 
different doses of DMBA at various ages either 21, 50 or 100 
days. Plotted is the percent of rats with either CIS or INV for 
each group, determined 3 months post-DMBA exposure. For all 
ages, n=5 rats (corn oil) and n=20 for each DMBA treated 
group.  
Based upon these data we could calculate the 
DMBA concentration necessary to induce tumors in 
50% of the rats for each age group (IC50) from probit 
curves fit to the data. These results are shown in Table 1 
as IC50 with 95% confidence intervals. 
Table 1. Calculated IC50 for Charles River SD 
Age at Initiation (days)  IC50 (mg/kg)  95% CI 
21 21.86  18.80-25.41 
50 14.03  11.65-16.85 
100 5.11  2.22-10.59 
 
Historical reports suggest that DMBA exposure at 
times other than the 50 day old optimum leads to an 
increased frequency of benign tumors. Table 2 shows 
the data for each DMBA dose and time of exposure for 
all tumor types. The benign category includes either 
fibroadenoma or adenoma with no malignant 
component. The CIS category includes CIS with no 
benign component. Mixed is CIS within a benign 
tumor. INV is invasion derived from CIS; we have not 
yet encountered an invasive DMBA-induced tumor in 
any study that was not clearly related to an adjacent 
CIS. As with the dose response for all other 
DMBA-induced pathologies, benign lesions increased 
with DMBA dose at all ages. However, there was no 
relationship between frequency of benign or mixed 
pathologies and age of DMBA exposure.  
Table 2. Tumor Distribution by Type in Percent (and Total 
Count) 
DMBA (mg/kg)  Benign  Mixed  CIS  INV 
A   21 Days  
0(oil)  0 (0/0)  0 (0/0)  0 (0/0)  0 (0/0) 
20  0 (0/35)  9 (3/35)  91 (32/35)  0 (0/35) 
50  2 (2/105)  17 (18/105)  81 (85/105)  0 (0/105) 
100  1 (1/157)  7 (11/157)  87 (137/157)  5 (8/157) 
 
B   50 Days  
0(oil)  0 (0/0)  0 (0/0)  0 (0/0)  0 (0/0) 
10  0 (0/11)  9 (1/11)  82 (9/11)  9 (1/11) 
30  2 (2/65)  3 (3/65)  94 (61/65)  2 (2/65) 
60  3 (5/168)  18 (30/168)  78 (131/168)  1 (2/168) 
 
C   100 Days  
0(oil)  0 (0/0)  0 (0/0)  100 (1/1)  0 (0/0) 
25  0 (0/91)  1 (1/91)  97 (88/91)  2 (2/91) 
50  0 (0/81)  2 (2/81)  95 (77/81)  2 (2/81) 
80  1 (1/183)  10 (18/183)  84 (154/183)  6 (10/183) 
Charles River Sprague Dawley Female Rat 
Mammary Gland Morphology 
To further characterize the nature of the 
carcinogenic process, we examined the mammary 
glands from each rat for precursor lesions and the 
morphology of the uninvolved mammary epithelium. 
The percentage of rats per group with IDPi, IDPp, CIS, 
and INV is shown in Figures 2a-c. Note all stages of 
pathology were identified at all doses at all ages. The 
21 and 50 day cohorts show a dose response for each 
precursor lesion. INV is rare in all cohorts being most 
common at higher dosages. This is expected given that 
analyses are performed only three months post-DMBA 
exposure. Note that occasional precursor pathologies 
are found in the corn oil exposed 50 day and 100 day 
cohorts. The mean multiplicity per group for each 
pathology is shown in Figures 2d-f. There is a rough 
dose dependence for multiplicity of proliferative 
lesions and CIS among all groups. The corn oil control 
group in the 100 day cohort also had a reasonable 
frequency of proliferative lesions.   Int. J. Biol. Sci. 2007, 3 
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Figure 2. (a) Percent of rats with incidence of various pathologies when treated with 0 (corn oil), 20, 50 and 100 mg/kg BW DMBA 
at 21 days of age; (b) at 50 days of age; (c) at 100 days Plotted is the percent of rats with each pathology for each treatment group, 
determined 3 months post-DMBA exposure for n=5 rats (corn oil) and n=20 for each DMBA treated group. (d) is the number of 
pathologies per rat when treated with 0 (corn oil), 20, 50 and 100 mg/kg BW DMBA at 21 days of age; (e) at 50 days, and (f) at 100 
days. Plotted is the mean + s.d. number of each pathology per rat for each group, determined 3 months post-DMBA exposure for n=5 
rats (corn oil) and n=20 for each DMBA treated group. 
 Int. J. Biol. Sci. 2007, 3 
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Charles River Sprague Dawley Female Rats Have 
Increase Susceptibility to Pituitary Hyperplasia, 
Adenomas, and Spontaneous Carcinomas  
Figure 3 shows the types of histology found 
within the mammary glands of the 100 day cohort 
exposed only to a single oral gavage of corn oil three 
months prior to sacrifice. The mammary glands varied 
from lobules with milk-filled cystic spaces (as 
indicated by arrows) with fat globules (Figure 3a), 
lobules that were massively expanded with milk 
(indicated by * as in Figure 3b), and milk filled ducts 
(Figure 3c). Numerous animals with highly 
milk-expanded ducts were found in all treatment 
groups at this age. 
In order to better understand the mammary 
gland morphology of the 100 day cohort with respect 
to the milk-filled cystic spaces, we examined the 
pituitary glands from female Sprague Dawley CDR 
IGS rats obtained from Charles River Laboratories. 
Immunohistochemical staining for prolactin in the 100 
day animals showed a higher percentage of 
lactotrophs. An example of the histology from each 
strain is shown in Figure 4 (a and b). Panel (a) 
represents a low magnification view of the pituitary 
gland from a 100 day old representative vehicle control 
female rat; all other rats at that age showed a similar 
level of positive prolactin staining. Although not 
quantitative, these data suggest that lactotroph 
hyperplasia is present early in adult life and may be 
responsible for the lactational events seen at six 
months of age. By contrast, matched tissue from a 
representative vehicle control female Taconic CD (b) of 
the same age showed minimal prolactin secretion.  
Charles River CD IGS Rats Have Accelerated 
Mammary Gland Development  
Given the morphological correlates related to the 
early mammary gland susceptibility, we examined rat 
mammary gland 4 whole mounts for developmental 
characteristics at the ages in which we had given 
DMBA (21, 50 and 100 days). These data are 
summarized in Figure 5. As predicted by the 
lactational phenotype, at 100 days of age there is 
significantly advanced lobular maturation in the 
mammary gland with numerous type 2 lobules and 
even a few type 3 lobules, reminiscent of a 
pseudopregnant state. All of the animals at 100 days of 
age had fluid filled lobules and fat globules within the 
epithelium, but none had undergone the proliferation 
necessary to form fully lactational type 4 lobules.  
 
Figure 3. Panels (a) (b) and (c) are representative samples of 
histological sections of mammary glands from virgin corn oil 
treated rat at time of sacrifice (approx. 190 days old). The tissue 
sections are stained with HE and all are x 20 magnification. The 
arrows in panel (a) indicate milk-filled cystic spaces; in panel 
(b) the * indicates specific lobules which are massively 
expanded by milk; panel (c) shows milk filled ducts. Int. J. Biol. Sci. 2007, 3 
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Figure 4. Panels (a) and (b) show histological sections of 
pituitary glands confirmed by hematoxalin and eosin staining 
(not shown) from 100 day old virgin rats dosed with vehicle then 
sacrificed at approximately 190 days of age. The tissue sections 
are stained for prolactin and both are at a 10X magnification. 
Panel (a) is taken from a Charles River Sprague-Dawley rat 
while panel (b) is from a Taconic Sprague-Dawley rat.  
 
4.  Discussion 
Many studies examining genetic and promotional 
events in mammary carcinogenesis utilize the Sprague 
Dawley rat. Based upon our previous experience with 
Sprague Dawley rats from Taconic and previously 
published data in this strain, three DMBA doses were 
chosen for administration at weaning (21 days), 50 
days, and 100 days of age. The expectation was that the 
most sensitive period for DMBA initiation would be 
the 50 day cohort with higher concentrations of DMBA 
required to reach a 50% incidence for tumors at 
younger and older ages in which one would predict 
fewer sensitive structures. Surprisingly, rather than the 
classical U-shaped dose curve in which there was 
maximum sensitivity for DMBA at 50 days, there 
appeared to be an increasing degree of sensitivity with 
age, quite the opposite of any other data published, to 
date. Based on these data, the corn oil cohort became of 
some interest due to the clear presence of a 
carcinogenic process, absent any known initiator. 
Furthermore, at sacrifice of the cohort exposed to 
DMBA at 100 days of age, the majority of the animals 
w e r e  l a c t a t i n g ,  i n d e p e n d e n t  o f  D M B A  e x p o s u r e  o r  
dose. 
Because of these unexpected findings, we 
consulted with Charles River Laboratories regarding 
the Sprague Dawley CDR IGS breeding colonies and 
discovered that this outbred strain has a significant 
incidence of pituitary adenomas and mammary 
carcinomas. Data on their website (www.criver.com) 
compiled from 31 studies, reports that in two year old 
females, there is a 71% incidence of pituitary 
adenomas, 6% incidence of pituitary carcinomas, and a 
22% incidence of spontaneous mammary carcinomas. 
If the pituitary pathology in this strain occurs early 
and the adenomas are prolactin producing, it would 
explain the lactational morphology and the early 
incidence of mammary tumors we observed in control 
rats. At some time in the past in the Charles River 
breeding stock, an increased susceptibility to pituitary 
hyperplasia, adenoma, and carcinoma developed. 
Prolactin is a major promoter of mammary 
tumorigenesis independent of the level of mammary 
differentiation, [25] and may even overcome the 
inhibitory effect of preganancy-induced terminal 
differentiation of the mammary gland [26]. Our data 
show that on this background of pituitary stimulation, 
the window of susceptibility for mammary 
tumorigenesis disappears in this rat strain. 
The classical window of susceptibility for 
mammary carcinogenesis correlates with the highest 
density of TEB. In the SD rat this is usually about 45-50 
days of age. In older rats, the TD is also reported to be 
a carcinogen sensitive structure. Carcinogens given 
before or after this period will yield fewer tumors. The 
reasons for this heightened sensitivity are still under 
study by numerous groups and may involve 
physiological factors and mammary gland stem cell 
populations that are uniquely present at this age. At 
the classical age of maximum sensitivity to 
carcinogenesis, 50 days, the Charles River animals had 
already undergone differentiation into type 1 and 2 
lobules with about 10% each residual TEB, TD, and 
AB. This is in contrast to the predicted morphology at 
this age in which TEB are rapidly being converted into 
AB [4]. Carcinogen sensitivity at this age correlates 
most directly with TD formation. Interestingly, at this 
time of weaning, the Charles River animals already 
had a significant number of type 1 lobules. The Charles 
River animals by 100 days of age show lactational 
changes, consistent with a pseudopregnant state. To 
our knowledge no one has published carcinogen 
sensitivity in this strain of outbred Sprague Dawleys in 
recent years. Here we have the opportunity to examine 
the correlation of carcinogen sensitivity and mammary 
structure on the background of prolactin stimulation. 
Our data suggest that pathologies that induce a change 
in physiological status, such as pituitary hyperplasia, 
alter the timing of maximum sensitivity to 
carcinogenic insults. Indeed, in older animals pituitary Int. J. Biol. Sci. 2007, 3 
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hormones are sufficiently promotional that a few 
percent of animals develop mammary tumors. In the 
Charles River line of SD rat, these pituitary events 
most likely explain the dose curve analyses showing a 
rapidly diminishing dose of carcinogen necessary to 
induce mammary carcinogenesis beginning at 
weaning.  
Recently, there has been a considerably renewed 
interest in mammary gland morphology and timing of 
development as data have shown that in utero and 
perinatal hormonal exposures may change the rate and 
timing of maturation [27-29]. In order to assess 
alterations in lifetime risk to agents in the 
environment, one must be aware of how optimal 
timing of sensitivity may differ by agent and the 
sensitive period may vary due to environmental 
factors. For example, if an exposure moves the timing 
of TEB to AB formation to a younger age than the 
classical 45-50 day window, an analysis of sensitivity 
at that age using DMBA may falsely show a preventive 
effect, whereas, in fact, one has simply moved the most 
sensitive period to a younger age. Therefore, 
characterization of mammary carcinogenesis risk must 
be analyzed on the background of how the agent 
under study or other confounding influences alters the 
rate of mammary gland maturation. 
 
Figure 5. Panels (a), (b), and (c) show mammary morphology from animals at (a) 21 days, (b) 50 days, and (c) 100 days. Int. J. Biol. Sci. 2007, 3 
 
415
5.  Summary 
The DMBA dose curves reported here highlight 
the difficulty in assuring physiological characteristics 
of animal strains over time. At some time in the past in 
the Charles River breeding stock, an increased 
susceptibility to pituitary hyperplasia, adenoma, and 
carcinoma developed. This has significantly altered the 
physiology of these animals such that pituitary 
hormones elicit early lactational events in virgins and 
promote mammary tumors in animals at a young age 
absent known carcinogenic insults. We briefly 
examined the pituitaries for prolactin, but clearly other 
pituitary hormones may also be over-produced in this 
strain. 
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